Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Balzarini

Showing results (351-360 of 563) with videos related to

Pageof 57
Sort By:
Antimicrobial Agents and Chemotherapy|December 1, 1994
The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replicationJ Neyts, G Andrei, R Snoeck, et al.
Journal of Virology|September 1, 1993
Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapyJ Balzarini, A Karlsson, M J Pérez-Pérez, et al.
Molecular Pharmacology|November 1, 1996
Antiretrovirus specificity and intracellular metabolism of 2',3' -didehydro-2',3'-dideoxythymidine (stavudine) and its 5'-monophosphate triester prodrug So324J Balzarini, H Egberink, K Hartmann, et al.
Chemical & Pharmaceutical Bulletin|March 1, 1993
Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. IIT Maruyama, Y Hanai, Y Sato, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1988
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agentsR Pauwels, J Balzarini, D Schols, et al.
Journal of Medicinal Chemistry|October 29, 1993
TSAO analogues. 3. Synthesis and anti-HIV-1 activity of 2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl 3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) purine and purine-modified nucleosidesS Velázquez, A San-Félix, M J Pérez-Pérez, et al.
Journal of Medicinal Chemistry|March 15, 2000
Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylaseA Esteban-Gamboa, J Balzarini, R Esnouf, et al.
Molecular Pharmacology|July 1, 1987
The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosidesJ Balzarini, G J Kang, M Dalal, et al.
Journal of Virological Methods|June 1, 1987
Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virusR Pauwels, E De Clercq, J Desmyter, et al.
Antiviral Research|March 18, 2004
The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapyP Borst, J Balzarini, N Ono, et al.
Pageof 57

Showing results (351-360 of 563) with videos related to

Sort By:
Pageof 57
Antimicrobial Agents and Chemotherapy|December 1, 1994
The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replicationJ Neyts, G Andrei, R Snoeck, et al.
Journal of Virology|September 1, 1993
Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapyJ Balzarini, A Karlsson, M J Pérez-Pérez, et al.
Molecular Pharmacology|November 1, 1996
Antiretrovirus specificity and intracellular metabolism of 2',3' -didehydro-2',3'-dideoxythymidine (stavudine) and its 5'-monophosphate triester prodrug So324J Balzarini, H Egberink, K Hartmann, et al.
Chemical & Pharmaceutical Bulletin|March 1, 1993
Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. IIT Maruyama, Y Hanai, Y Sato, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1988
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agentsR Pauwels, J Balzarini, D Schols, et al.
Journal of Medicinal Chemistry|October 29, 1993
TSAO analogues. 3. Synthesis and anti-HIV-1 activity of 2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl 3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) purine and purine-modified nucleosidesS Velázquez, A San-Félix, M J Pérez-Pérez, et al.
Journal of Medicinal Chemistry|March 15, 2000
Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylaseA Esteban-Gamboa, J Balzarini, R Esnouf, et al.
Molecular Pharmacology|July 1, 1987
The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosidesJ Balzarini, G J Kang, M Dalal, et al.
Journal of Virological Methods|June 1, 1987
Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virusR Pauwels, E De Clercq, J Desmyter, et al.
Antiviral Research|March 18, 2004
The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapyP Borst, J Balzarini, N Ono, et al.
Pageof 57